Method for identifying genetically modified chicken through direct PCR (Polymerase Chain Reaction) of blood

Through the direct blood PCR identification method, the genetic modification process of chicken PGCs is simplified, the cumbersome and cost-effective problems in the existing technology are solved, efficient and accurate identification of genetically modified chickens is achieved, and the poultry breeding quality is improved through "surrogacy" technology Resource conservation efficiency.

CN118932086APending Publication Date: 2024-11-12ANIMAL SCI RES INST GUANGDONG ACADEMY OF AGRI SCI +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411299320.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-18
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

During the genetic modification of chicken PGCs, the existing PCR identification methods are cumbersome and the chickens are stressful, and DNA is required to be extracted, resulting in large workloads and high costs.

Method used

Direct blood PCR identification method was used, and the chicken toe blood was collected and added to EDTA solution, centrifuged, shocked, and left to stand. The supernatant was used as a template for PCR reaction, and genomic DNA amplification was performed using a specific Taq enzyme.

Benefits of technology

The blood collection process is simplified, the workload and cost are reduced, the identification efficiency of genetically modified chickens is improved, and the seed maintenance efficiency of poultry germplasm resources is improved through the "surrogacy" technology of gene-edited chickens.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118932086A_ABST
    Figure CN118932086A_ABST
Patent Text Reader

Abstract

The invention discloses a method for identifying genetically modified chicken through direct PCR (polymerase chain reaction) of blood. Belongs to the technical field of PCR identification. The method comprises the following steps: collecting chicken blood and adding the chicken blood into a centrifugal tube containing EDTA (Ethylene Diamine Tetraacetic Acid) to obtain a pretreatment solution; centrifuging, discarding the supernatant, adding pure water, fully oscillating, standing, and absorbing the supernatant as a template; and carrying out PCR reaction. The chicken toe blood is directly collected for PCR identification, the blood collection method is simple, DNA does not need to be extracted, the cost is reduced, and the workload is greatly reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of PCR identification, and more specifically to a method for directly identifying gene-modified chickens through blood PCR. Background Art

[0002] Chickens have been widely used in early embryogenesis, toxicology, and stem cell research, especially in bird gene modification (transgenic and genome editing, etc.). Primordial germ cells (PGCs) are the ancestral cells of spermatogonia and oogonia, and can pass genetic information to the next generation. After in vitro culture and genetic modification, PGCs still maintain their biological characteristics. After transplantation and reinjection into the chicken embryo's blood system, they can migrate to the gonads and develop into functional gametes, producing genetically modified offspring. PGCs combined with CRISPR / Cas9 technology to produce genome-modified chickens are the most widely used and mature genome modification models in birds, including models such as the introduction of LOXP sites into chicken IgH sites, the insertion of GFP genes into Z chromosomes, and chickens resistant to J subtype avian leukosis and avian influenza.

[0003] In the process of producing genetically modified chickens based on chicken PGCs, three generations (G0, G1 and G2 generations) are required, and each generation must be PCR identified to identify the positive chickens with genetic modification, which is a very large workload. For example, in the G1 generation, if 200 positive G1 generation hens are to be obtained for the production of the G2 generation, based on a positive chicken ratio of approximately 20%, more than 2,000 G1 generation chickens need to be PCR identified (calculated at a male to female ratio of 1:1). The existing PCR identification method generally involves collecting blood or tissue to extract DNA, and then using the extracted DNA as a template for PCR identification. Moreover, in order to obtain sufficient blood, cardiac blood sampling is generally performed on one-day-old chicks, which is cumbersome and causes great stress on the chickens.

[0004] In summary, how to provide a simple, efficient and accurate method for identifying genetically modified chickens is an urgent problem that technicians in this field need to solve. Summary of the invention

[0005] In view of this, the present invention provides a method for identifying genetically modified chickens by direct PCR in blood.

[0006] Difficulties of the present invention:

[0007] (1) Since the amount of red blood cells is difficult to control during the blood collection process, it is necessary to constantly explore how much pure water to add when lysing red blood cells and how long to shake and lyse them after adding pure water.

[0008] (2) Since the blood template contains impurities such as proteins and lipids, it is crucial to select the appropriate Taq enzyme.

[0009] In order to achieve the above object, the present invention adopts the following technical solution:

[0010] A method for identifying genetically modified chickens by direct PCR in blood comprises the following steps:

[0011] (1) Collect chicken blood and add it into a centrifuge tube containing EDTA to obtain a pretreatment solution;

[0012] (2) Centrifuge and discard the supernatant, then add pure water, shake thoroughly, let stand and then aspirate the supernatant as a template;

[0013] (3) Perform PCR reaction.

[0014] Furthermore, the chicken blood is toe blood.

[0015] Furthermore, in step (1), 10-20 μL of chicken blood is added to 150 μL of EDTA solution having a mass concentration of 1.5%.

[0016] Furthermore, in step (2), the centrifugation parameters are 3000 rpm for 3 min.

[0017] Furthermore, in step (2), the volume ratio of the pretreatment liquid to pure water is 15:10.

[0018] Furthermore, in the step (2), the shaking time is 3 to 5 minutes.

[0019] Furthermore, in the step (2), the standing time is 10 minutes.

[0020] Furthermore, in step (3), the Taq enzyme added to the PCR reaction is ApexHF HSDNA polymerase premix - FS (containing dye) produced by Acori Biotech.

[0021] Furthermore, the exogenous gene in the genetically modified chicken is icaspase9-HA-T2A-EGFP, and its nucleotide sequence is shown in SEQ ID No.1.

[0022] It can be seen from the above technical solution that, compared with the prior art, the beneficial effects achieved by the present invention are:

[0023] (1) The present application directly collects blood from chicken toes for PCR identification. The blood collection method is simple and does not require DNA extraction, which reduces costs and greatly reduces workload.

[0024] (2) When red blood cells are lysed in a hypotonic environment, genomic DNA is released, which can be used as a template. One only needs to select an enzyme with strong specificity and tolerance to complex templates and design appropriate primers to amplify the target fragment in the genome.

[0025] (3) The gene-edited chickens obtained in this application can induce apoptosis of endogenous PGCs through B / B drugs, and establish a "surrogate" intermediate host chicken population. In this way, exogenous PGCs (any other chicken breeds) can be injected into the "surrogate" intermediate host chicken population, so that the exogenous PGCs (and only exogenous PGCs) continue to develop in the body and can be bred when they reach sexual maturity. Using "surrogate" chickens, a new method of poultry in vitro seed preservation is created, which greatly improves the efficiency of local chicken seed preservation and lays a good foundation for the in vitro preservation of poultry germplasm resources. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying creative work.

[0027] Figure 1 This is the sequencing verification result of the gRNA scaffold sequence in the gene editing plasmid in Example 1 of the present invention;

[0028] Figure 2 The apoptosis induction test results in Example 1 of the present invention;

[0029] Figure 3 The expression of green fluorescent protein in the gonads of chicken embryos was observed under a fluorescence microscope in Example 1 of the present invention;

[0030] Figure 4 The expression of DAZL, iCas9 and GFP genes was identified by PCR in the semen of the G0 generation rooster in Example 1 of the present invention;

[0031] Figure 5 The blood PCR identification results in Example 1 of the present invention, the first number of the lane number is the family;

[0032] Figure 6 The results of iCas9 gene identification by LFM-G1 blood PCR and DNA PCR in Example 1 of the present invention;

[0033] Figure 7 The results of GFP gene identification by LFM-G1 blood PCR and DNA PCR in Example 1 of the present invention;

[0034] Figure 8 The results of the DAZL gene identification by LFM-G1 blood PCR and DNA PCR in Example 1 of the present invention;

[0035] Fig. 9This is the amplification result of Comparative Example 1 of the present invention. DETAILED DESCRIPTION

[0036] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0037] The experimental materials used in the embodiments of the present invention are as follows:

[0038] Breeding eggs and chickens were sourced from the original breeder farm of the Animal Science Institute of Guangdong Academy of Agricultural Sciences and incubated at 38.5°C and 60% relative humidity to the required age.

[0039] DMEM, chicken serum, fetal bovine serum, PBS solution, double antibody, non-essential amino acids, GlutaMAX TM , sodium pyruvate, B27 supplement solution, amino acid solution, albumin, heparin sodium and pancreatic enzyme were purchased from Gibco.

[0040] rhFGF was purchased from R&D systems.

[0041] Human Activin A was purchased from PeproTech.

[0042] β-Mercaptoethanol was purchased from Sigma.

[0043] HiPure FFPE DNA kit was purchased from Guangzhou Meiji Biotechnology Co., Ltd.

[0044] ApexHF HS DNA polymerase premix-FS (containing dye) was purchased from Guangzhou Aikerui Biotechnology Co., Ltd.

[0045] EZNATM Plasmid Mini Kit I was purchased from OMEGA.

[0046] The recombinase NEBuilder® HiFi DNA Assembly was purchased from Gene Co., Ltd.

[0047] The transfection reagent lipo2000 was purchased from the Thermo Fisher official store.

[0048] The sex identification primer sequences used in the examples are:

[0049] F: 5'-GTTACTGATTCGTCTACGAGA-3', SEQ ID No. 2;

[0050] R: 5'-ATTGAAATGATCCATGCTTG-3', SEQ ID No. 3.

[0051] Example 1

[0052] 1. Isolation and culture of chicken PGCs

[0053] Prepare several eggs that have been incubated for 5-7 days, sterilized No. 5 surgical forceps, ordinary forceps, etc., and irradiate the cell chamber with ultraviolet light for 30 minutes in advance. Wipe the tip of the egg with an alcohol cotton ball, knock a hole with ordinary forceps, carefully remove the embryo with forceps, place it in a culture dish filled with PBS solution, and remove the yolk particles on the surface of the embryo. Transfer the cleaned embryo to a new PBS solution, cut open the abdomen with forceps, and find a pair of white and transparent gonadal tissues on the mesonephros. Gently peel off a pair of gonads from the mesonephros and transfer them to a 1.5 ml centrifuge tube containing 300 µl PBS solution, add 100 µl of 0.25% Trypsin / EDTA solution and place it in a 37℃ incubator for digestion for 15 minutes. 400 µl of culture medium containing 10% fetal bovine serum was added for neutralization, and then centrifuged at 500 g for 5 min at room temperature, and the supernatant was discarded; the cell pellet was resuspended in 300 µl of chicken PGCs culture medium, transferred to a 48-well plate and placed for 3-4 h, and then the supernatant was transferred to a new well for continued culture. The incubator conditions were 37°C and 5% CO2. The culture medium was replaced every 2.5 days, and chicken primordial germ cells were passaged every 3-4 days. After 3 weeks of culture, the cell surface marker protein SSEA1 was detected by immunofluorescence.

[0054] As a result, the present invention isolated 50 chicken embryos in total, of which 10 male and 6 female PGCs had a cell number of 10 before the end of the third week. 6 Pieces / ml.

[0055] (II) Construction of vector carrying iCas9-2A-GFP protein

[0056] (1) Construction of vector

[0057] Donor plasmid construction: The eukaryotic expression vector backbone pcDNA3.1(+) was purchased from Invitrogen™, and the insert fragment icaspase9-HA-T2A-EGFP was synthesized by Beijing Qingke Biotechnology Co., Ltd. The pcDNA3.1(+) vector was linearized by Hind III digestion, and the insert fragment icaspase9-HA-T2A-EGFP was amplified by PCR to obtain a linearized fragment. Then, the recombination reaction system was prepared according to the NEBuilder® HiFi DNA Assembly manual. The two fragments were mixed at an equal molar ratio, reacted at 50°C for 1 h, and then placed on ice for use.

[0058] Construction of gene editing plasmid: px459 plasmid (Addgene #62988) was purchased from Addgene, and the singleguide RNA (sgRNA) sequence was synthesized by Beijing Qingke Biotechnology Co., Ltd. The synthesized sense and antisense single-stranded gRNA1 was annealed by gradient cooling, and the px459 vector was linearized by Bbs I digestion. Finally, the annealing product and the vector were ligated with T4 DNA ligase at 4°C overnight, and the ligated product was placed on ice for later use.

[0059] The nucleotide sequence of the single guide RNA (sgRNA) is as follows:

[0060] ATCTTACTAAACTGAACTGT, SEQ ID No. 4.

[0061] The nucleotide sequence of the inserted fragment icaspase9-HA-T2A-EGFP is as follows:

[0062]

[0063] (2) Transformation of ligation products into competent cells DH5a

[0064] Thaw the stored competent cells DH5α in ice, take 30 μL of competent cells and 10 μL of ligation product and gently mix, place in an ice bath for 30 min, heat shock at 42 ℃ for 90 s, quickly transfer to an ice bath and cool for 2-3 min, add 1 mL of LB liquid culture medium without antibiotics, shake and culture at 37 ℃ and 160 r / min for 1 h, take 200 μL of bacterial solution and spread on LA plates, and culture at 37 ℃ overnight.

[0065] (3) PCR identification of positive colonies

[0066] A single white colony was picked from the plate cultured above, inoculated into 1 mL of LB liquid culture medium containing ampicillin, and cultured at 37°C with shaking at 220 r / min for 12-16 h. Primers were designed and the bacterial solution was directly used as a template for PCR identification. The reaction system and procedure were carried out according to the instructions of the Acryl Mix kit. The PCR product was detected by 1% agarose gel electrophoresis.

[0067] The nucleotide sequences of the donor plasmid primers are as follows:

[0068] pc-iCaspase9-F1

[0069] GAGACCCAAGCTGGCTAGCGTTTAAACTTAATGCTGGAGGGAGTGCAGGT, SEQ ID No. 5;

[0070] pc-iCaspase9-R1

[0071] ACTGGACTAGTGGATCCGAGCTCGGTACCAtcacttgtacagctcgtcca, SEQ ID No. 6.

[0072] The nucleotide sequences of the gene editing plasmid primers are as follows:

[0073] DAZL-gRNA1-F1

[0074] caccgTTCTTACTAAACTGAACTGT, SEQ ID No.7;

[0075] DAZL-gRNA1-R1

[0076] aaacACAGTTCAGTTTAGTAAGAAc, SEQ ID No. 8.

[0077] (4) Plasmid extraction, identification and sequencing

[0078] The positive bacterial liquid was re-inoculated into 5 ml LB liquid culture medium containing Amp, and cultured at 37℃ 220 r / min in a shaking incubator for 12-16 h, referring to the instructions provided by OMEGA's EZNATM Plasmid Mini Kit I.

[0079] Take 1 μL of the extracted plasmid, select the restriction sites on both sides of the exogenous fragment for restriction digestion identification, and detect the restriction digestion results by electrophoresis. When the restriction digestion results are consistent with expectations, select 2 to 3 clones and send them to Shanghai Yingjun Biotechnology Service Co., Ltd. for forward and reverse sequencing. The sequencing results and the target sequence are analyzed. The results show that the exogenous fragment has been correctly inserted into the genome, with a contrast ratio of 100% and no mutations. Some sequencing results are shown in Figure 1 shown.

[0080] (5) Preparation of plasmid for transfection

[0081] The bacterial suspension of the two recombinant plasmids with correct sequencing was expanded and cultured at 37°C and 220 r / min for 12-16 h, and the bacterial cells were collected for endotoxin-free plasmid extraction. The operation was performed according to the instructions of the EZNATM EndoFee Plasmid Mini Kit II reagent of OMEGA Company.

[0082] Take 2 μL of plasmid and measure OD using a spectrophotometer. 260 and OD 280 Optical density absorbance value, R value = OD 260 / OD 280 Estimate the purity of plasmid DNA. Plasmid DNA with an R value between 1.8 and 2.0 and a supercoiled conformation >70% can be used for cell transfection experiments.

[0083] 3. Cell transfection

[0084] For the successfully established male individual PGC cell line, when the culture density reaches 1×10 6 When the number of cells was 1 cell / ml, 2 ml of cells were centrifuged at 500 g for 5 min, resuspended and washed twice with basal medium, and placed in complete medium. At the same time, the transfection reagent was prepared according to the reagent instructions, 1 μg of gene editing plasmid and donor plasmid each, and 6 μl of transfection reagent. The mixture was allowed to stand for 5 min and then added to the cells. The complete medium was replaced after 6 h.

[0085] 4. Flow cytometry sorting of PGCs stably expressing iCas9-2A-GFP protein

[0086] After transfection, continue to culture for 72 h, and use the GFP luminescent gene to sort positive cells using a flow cytometer. Before sorting, prepare a sterile operating solution (distilled water and 75% ethanol) to clean the flow cytometer (BDFACSAriaII). Collect chicken PGCs into a 15 mL centrifuge tube and suspend the cells with PBS. The cell density is greater than 10 6 First, use the positive control and negative control to set the sampling parameters and the range of the cross gate of the flow cytometer, and then sort the chicken PGCs. The sorted positive PGCs are cultured for 2 weeks until the cell density reaches 10 7 / mL, some cells were selected and added with iCaspase9 protein activating factor B / B reagent to test the cell apoptosis inducing ability.

[0087] The apoptosis induction test was performed on the PGCs cell lines stably expressing iCas9-2A-GFP protein obtained by screening. 0.1 nM B / B drug was added to the experimental group, and no drug was added to the control group. After 48 hours, the results were as follows: Figure 2 It was found that the cells in the control group grew normally, but a large number of cells in the experimental group underwent apoptosis, and only a small number of cells survived, proving that we have successfully constructed a drug-induced apoptosis PGC cell line.

[0088] 5. Transplantation of chicken PGCs stably expressing iCas9-2A-GFP protein into recipient chickens

[0089] Use a needle puller, a needle breaker, and a needle grinder to prepare microinjection needles (needle diameter 25~30µm, needle tip 30° bevel). Take male PGCs that stably express iCas9-2A-GFP protein, add 10% trypan blue, and mix well. Take 2~2.5 day old chicken embryos, open the egg shell 0.5~1 cm at the tip, find the dorsal aorta of the chicken embryo under a stereo microscope, and gently blow in 3 µL of a solution containing about 2000~5000 PGCs along the direction of blood flow with the needle bevel facing down. Apply egg white around the opening, seal the opening with a film, and after the egg white is dry, put it in the incubator to continue incubation.

[0090] There are two types of recipient chickens used for microinjection, one is the black six chicken and the other is the fast large yellow chicken.

[0091] The male PGCs cell line stably expressing iCas9-2A-GFP protein was injected into 400 recipient chicken embryos at 2-2.5 embryonic ages (200 of which were black six chickens and the other 200 were fast large yellow chickens). 359 of them were successfully injected and placed in an incubator for further incubation. At 6.5-7.5 embryonic ages, 4 chicken embryos were taken to separate the gonads, and under a fluorescence microscope, it was observed that the gonads of 3 chicken embryos expressed green fluorescent protein ( Figure 3), indicating that the PGCs isolated and screened by the present invention can continue to develop in recipient chickens. The remaining chicken embryos continue to be incubated until hatching.

[0092] (VI) Identification and mating of G0 generation roosters carrying iCas9-2A-GFP protein

[0093] After the injected eggs hatch, only the roosters (G0 generation) are kept and raised to sexual maturity. After sexual maturity, semen is collected to extract DNA, and the specific operation is carried out according to the instructions of the HiPure FFPE DNA kit. Identification primers are designed for the genome and exogenous insertion fragments, and DNA is used as a template for PCR identification. The reaction system and procedures are carried out according to the instructions of the Aikuri Mix kit, and the PCR product is detected by 1% agarose gel electrophoresis. Three pairs of primers, BY1 (to detect iCas9 sequence), BY2 (to detect GFP sequence) and DAZL (primers at both ends of the insertion fragment) are used for detection. If all are positive, it means that the iCas9 and GFP sequences have been successfully inserted into the DAZL locus, and they are identified as positive for breeding. The results are as follows Figure 4 As shown ( Figure 4 For the quick results of large yellow chicken).

[0094] The hatching results showed that 83 embryos of the fast-growing yellow chickens survived, of which 33 were male. The male chickens were raised to 4 months old, and semen was collected to extract DNA for PCR identification. The results showed that semen could be collected from 16 roosters among the 33 fast-growing yellow chickens, and the expression of iCas9 and GFP genes was detected in 11 of them. 43 embryos of the black six chickens survived, of which 19 were male. The PCR test results showed that the expression of iCas9 and GFP genes could be detected in 5 roosters of the black six chickens.

[0095] The G0 generation roosters carrying the iCas9-2A-GFP protein were mated with hens and placed in an incubator to hatch.

[0096] There are two types of hens used for mating. One is the mating of Hy-Line brown laying hens with black six chickens, and the other is the mating of medium-speed yellow chicken hens with fast-sized yellow chickens.

[0097] The primer sequences are as follows:

[0098] DAZL-F1: AGGCACCTGTACTGTGAAACC, SEQ ID No. 9;

[0099] DAZL-R1: GCAGGAAAGCATGCAAGCTAG, SEQ ID No. 10;

[0100] BY1-F1: GCTCTTGGTACGTGGAGACC, SEQ ID No.11;

[0101] BY1-R1: GGCGGACTTGAAGAAGTCGT, SEQ ID No.12;

[0102] BY2-F1: TGTTGGGCAGATTTGAAGAGGA, SEQ ID No. 13;

[0103] BY2-R1: GTGGCTCCGTATGCGTAGTC, SEQ ID No. 14.

[0104] 7. Identification of genetically modified chickens carrying iCas9-2A-GFP protein

[0105] After mating the G0 generation roosters carrying the stably expressed iCas9-2A-GFP protein with the hens, the breeding eggs were collected and incubated until the chicks hatched.

[0106] 1. Blood direct PCR method

[0107] On the day of hatching, follow the following process:

[0108] (1) To number the chicks, place a numbered label around the chicks’ ankles and secure with transparent tape.

[0109] (2) Weigh the chickens with the leg numbers attached and register them according to the numbers.

[0110] (3) Blood collection: Use scissors to cut the nail of the middle toe of the chicken's right foot, collect 15 μL of blood into a 1.5 ml centrifuge tube containing EDTA (150 μL PBS solution, 1.5% EDTA), shake well and label.

[0111] (4) PCR verification: Centrifuge the blood at 3000 rpm for 3 min, discard the supernatant; add 100 µl of pure water to lyse the red blood cells; shake thoroughly (vortex for 3-5 min), let stand for 10 min, and aspirate the supernatant as a DNA template. Use the primers in step (VI) to perform PCR experiments; the reaction system and procedures refer to the instructions of the Acre Biotech Mix kit (the enzyme is the ApexHF HSDNA polymerase premix - FS (containing dye) from Acre Biotech), and the PCR product is detected by 1% agarose gel electrophoresis.

[0112] 2. PCR method for DNA extraction

[0113] Four weeks after hatching, 300 μL of blood was collected from the wings and placed in a 1.5 ml centrifuge tube containing 1.5% EDTA in PBS solution. The tube was shaken thoroughly and labeled. DNA was extracted using MGBio's HiPure Viral DNA Kit (Cat. No. D3191-03) and DNA was extracted according to the instructions. The PCR reaction procedure and product detection were the same as above.

[0114] In this study, 11 G0-generation fast-growing large-sized yellow chicken roosters were mated with 48 medium-growing yellow chicken hens. A total of 326 eggs were collected in 12 days, and 277 chicks were hatched, including 130 roosters and 147 hens. The blood PCR identification results showed that a total of 54 positive chickens, including 22 roosters and 32 hens. The rooster test results are shown in Figure 5 .

[0115] In addition, this study used 3 G0-generation positive black six roosters to mate with 52 Hailan brown chickens, and collected a total of 120 breeding eggs, 98 chicks were hatched, including 51 roosters and 47 hens. The blood PCR identification results showed that chicken No. 70 was a positive chicken ( Figure 6 , 7 , 8). As can be seen from the figure, the blood PCR results are consistent with the DNA PCR identification results.

[0116] Comparative Example 1

[0117] Collect 15 μL of blood from the toes of a one-day-old chick and place it in a 1.5 ml centrifuge tube with 150 μL EDTA. Centrifuge at 3000 rpm for 3 min, discard the supernatant, add 250 μL of pure water, and vortex for 5 min. Take 1 μL as a template and amplify the target fragment using the primer of DAZL.

[0118] The results are as follows Fig. 9 As shown, 21, 22, 23, 24, 37, 38, 40, 41, and 43 did not amplify the 441bp band, indicating that there is a problem with the DNA template. (Chicken blood sample No. 36 is missing)

[0119] The various embodiments in this specification are described in a progressive manner, and each embodiment focuses on the differences from other embodiments. The same or similar parts between the various embodiments can be referenced to each other.

[0120] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A method for identifying genetically modified chickens by direct PCR in blood, characterized in that: The steps include: (1) Collect chicken blood and add it into a centrifuge tube containing EDTA to obtain a pretreatment solution; (2) Centrifuge and discard the supernatant, then add pure water, shake thoroughly, let stand and then aspirate the supernatant as a template; (3) Perform PCR reaction.

2. The method according to claim 1, characterized in that The chicken blood is toe blood.

3. The method according to claim 1, characterized in that In the step (1), 10-20 μL of chicken blood is added to 150 μL of EDTA solution having a mass concentration of 1.5%.

4. The method according to claim 1, characterized in that In the step (2), the centrifugation parameters are 3000 rpm for 3 min.

5. The method according to claim 1, characterized in that In the step (2), the volume ratio of the pretreatment liquid to pure water is 15:

10.

6. The method according to claim 1, characterized in that In the step (2), the shaking time is 3 to 5 minutes.

7. The method according to claim 1, characterized in that In the step (2), the standing time is 10 minutes.

8. The method according to claim 1, characterized in that In the step (3), the Taq enzyme added to the PCR reaction is ApexHF HS DNA polymerase premix - FS.

9. The method according to any one of claims 1 to 8, characterized in that: The exogenous gene in the genetically modified chicken is icaspase9-HA-T2A-EGFP, and its nucleotide sequence is shown in SEQ ID No.1.